Antikor Biopharma Ltd
Company Details
Status: Private
Employees: 11-50
Location:
Gunnels Wood Road, Stevenage, England SG12FX, GB
Type:
sample
Technology:
sample
sample
sample
About: Antikor is a privately-held biotechnology company originally spun-out from Imperial College. We specialise in the discovery and development of small-format Antibody (Fragment) Drug Conjugates, known as FDCs. FDCs are a form of targeted cytotoxic chemotherapy combining the specificity of antibodies with the potency of small-molecule chemotherapy drugs. Specifically, FDCs are smaller than conventional Antibody Drug Conjugates (ADCs) meaning better tumour penetration and more rapid systemic clearance, potentially leading to a higher clinical therapeutic index. Antikor are developing the next-generation of solid tumour therapies, with a major interest in gastro-intestinal cancers.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Antikor Biopharma Ltd | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.